Calcium channel blockers key to reversing myotonic dystrophy muscle weakness

Calcium channel blockers key to reversing myotonic dystrophy muscle weakness

New research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy type 1 (DM1) and further shows that calcium channel blockers can reverse these symptoms in animal models of the disease. The researchers believe this class of drugs, widely used to treat a number of cardiovascular diseases, hold promise as … Read more